Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

PBRM1 deletion

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

PBRM1 deletion	Renal Cell Carcinoma	PBRM1 deletion	Renal Cell Carcinoma	atezolizumab Sensitive: C3 – Early Trials atezolizumab Sensitive : C3	atezolizumab Sensitive: C3 – Early Trials atezolizumab Sensitive : C3
PBRM1 deletion	Renal Cell Carcinoma	PBRM1 deletion	Renal Cell Carcinoma	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3
PBRM1 deletion	Clear Cell Renal Cell Carcinoma	PBRM1 deletion	Clear Cell Renal Cell Carcinoma	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3
PBRM1 deletion	Renal Cell Carcinoma	PBRM1 deletion	Renal Cell Carcinoma	sunitinib Resistant: C4 – Case Studies sunitinib Resistant : C4	sunitinib Resistant: C4 – Case Studies sunitinib Resistant : C4